Wednesday Bubble: Two is the Magic Number?
When it comes to Traditional Chinese Medicine (TCM), is two the magic number? A variety of studies have examined the utility of TCM for menopausal symptoms and some have shown good benefit. However, does combining distinct forms of TCM yield better outcomes? Moreover, are these outcomes equal to those achieved by hormone therapy?
They may very well be, according to a small study that was presented this past May at the International Research Congress on Integrative Medicine and Health. Published in BMC Complementary and Alternative Medicine, the study explores the use of a Chinese herbal formulation named Kun Bao Wan alone and in combination with acupuncture and compares it to hormone therapy. Available in powder form and priced at approximately $8.00 a box, Kun Bao Yan is used in Chinese medicine to balance hormone levels, relieve insomnia and improve blood circulation to restore healthy metabolism. A web and database search yielded almost no information on side effects, reinforcing the need to work directly with a practitioner versed in Chinese medicine versus using it on your own.
Regardless, over a two-month period, 57 women in peri- or full on menopause took Kun Bao Wan (5 gm. twice a day) alone or in combination of 5 acupuncture sessions a month, or were assigned hormone therapy. During this time, symptoms (hot flashes, tingling, insomnia, nervousness, weakness, dizziness, palpitations) were measured with a scientifically validated index. The researchers also assessed hormone levels (FSH, estradiol) and symptom severity and frequency.
The findings appear to indicate that while all three strategies can significantly decrease menopause symptom scores, better results were achieved with Chinese medicine plus acupuncture compared to Chinese medicine alone, particularly in women who were postmenopausal. Additionally, Chinese medicine plus acupuncture was on par with hormone therapy with regards to its overall effects on FSH. Importantly, none of these strategies appeared to affect levels of circulating natural estradiol.
Granted, this study is quite small. But it does show that with Chinese Medicine, two combined modalities may be better than one. And are certainly on par with hormone therapy — and perhaps even safer.
Read More
Menopause: a disease. Or not?
For some time now, I have been writing about the medicalization of menopause and about the Menopause Industrial Complex and its implication for how the life transition is currently managed, understood and communicated. And if you are a regular reader of this blog, you know that I find it appalling how society has managed to change how we perceive a biologically natural transition from a positive to a negative. Consequently, I was intrigued when I stumbled across a research article in BioMedCentral Medical Education journal discussing the role of medical education in driving how future clinicians view a constellation of symptoms as the norm (or not) and how they subsequently label them as a result.
Not surprisingly, how something is labeled drives practitioner atttiudes towards management and treatment.
Writing in the journal, the study’s co-authors say that “The labelling of a condition as a “disease” has important implications…failing to label a condition as a disease may mean effective treatment is not prescribed, labeling a non-condition as a disease may result in unnecessary treatment.” Moreover, they point out that data have shown that such labelling leads to greater numbers of prescriptions. And, that labeling a spectrum of symptoms incorrectly may promote anxiety about prognosis and overtreatment.
Fortunately, in this study of 190 medical students, approximately 80% concurred that menopause was a “non-disease.” And yet, one has to wonder that if a cohort of licensed practitioners were surveyed, the results would be the same?
Despite the fact that the rates of prescriptions for hormone replacement therapy have significantly declined, the historical construct of the menopause has long been associated with loss, decline and decay, something is abhorred and shunned in society. In response, marketers and the media have perpetuated and pathologized what author Louise Foxcroft (in her book, ‘Hot Flushes, Cold Science’) refers to as “one more feature in a woman’s linear life history, an inevitable and natural phenomenon, one more thing to negotiate and nowhere near as astonishing or potentially problematic as pregnancy.”
It is all in how you/we view it. And how our practitioners view and label it.
If you are encouraged by the future of medicine, let’s take a look at the ‘now.’
Cynical as I may be about society’s vision of the aging woman, I was further dismayed when my friend and esteemed colleague, Ivan Oransky forwarded an article outlining a small study of residents that participated in a menopause clinic rotation. Within this rotation, the residents had an opportunity review each case after menopausal women were seen and additionally, were offered after-hour lectures to enhance their knowledge and education.
Overall, the findings demonstrated that it was the clinical contact with the women and not sporadic instruction, that significantly impacted residents’ ability to thoroughly understand issues relating to menopause and women’s health (this was evidenced by mean improvements in menopause test scores by 13%). And yet, as the study authors point out, most resident education is currently based on didactics and not face-to-face contact. This implies that these results, however favourable, may not be applicable to the real world.
Another overlooked challenge in this particular case is the adjunctive educational opportunities offered to the resident physicians. In addition to colleague-directed knowledge or realtime clinical experience, they were provided with an opportunity to purchase educational materials about menopause produced by Red Hot Mama’s. Herein lies the rub: Red Hot Mama’s, one of the oldest organizations for menopause, receives funding from Norogyne Pharmaceuticals and advertises Vivelle-Dot hormone replacement on its home page. You may recall that the organization even teamed up with Norogyne Pharma to pimp Vivelle up on a roof; you can find the post here.
The take-home message of these two studies is very clear: currently, medical students appear to be ‘in the know’ about menopause, at least in so far as how it should be classified. This divergent path has the potential to ultimately influence how menopause is viewed and managed in Western society. Moreover, there appears to be a realization that in certain situations real time clinical contact may supercede or significantly enhance didactic education. However, this education may be less valuable if it is driven by commercial interests. What concerns me most is that by the time these practitioners of the future get out into the real clinical world, they may possibly drink the the Kool-Aid or at least, taste it.
How do we approach this ironic paradigm that is being perpetuated and rewound, even by organizations organized to help the very women that they may ultimately be hurting?
Labels? It’s up to you. Menopause, is it a disease or not? And what are you going to do about it?
Read More
Time to End the Shhh…
I am discovering a pattern: when women learn about Flashfree, they inevitably tell me that they wish that they had a sounding board, someone to talk to about the aging-symptom paradigm, more exchange, more discourse. When I started this blog four years ago, I wanted to become a conduit for that conversation or at the very least, an inspiration. And I know that I’ve been inspired by the interest and the support.
Lately, it’s become so apparent that we need to talk more, listen more, explore more. We need each other.
The following was written during the early days of Flashfree and it’s as relevant now as it was then. So, in a bold move, I am reprising it, in hopes that it will begin that spark that I would like to see carry us through the rest of this year. It’s been a challenging one for many of us. And every day becomes a reminder of what’s most important and what is really not so important. Mostly though? I hope that this space continues to be as much yours’ as mine.
I was talking to a colleague/old friend the other day about this blog. She is a few years older than I and we got into this great conversation about generational gaps when it comes to discussing health issues. Perimenopause and menopause in particular have been huge taboo issues for women for decades.
Take for example, an episode from ‘That 70s Show,’ in which Kitty learns that she is not pregnant but rather, has entered menopause. When she asks her mother (played to a T by none other than Betty White) about her experience, she’s informed that she never went through menopause and has always been “healthy.” It’s funny and sad simultaneously. And definitely well worth the watch. (Fast forward to timecode 3:59.)
As the last of the baby boomers enter middle age, their appetites for health information appear to be ever more insatiable. And yet, some of the savviest and most practical women I know confess that they rarely, if ever, discuss their symptoms, moods or concerns about the changes that they are going through with their friends, let alone their mothers.
I’m fortunate. I have a mother who is pretty open about these sort of topics. And although she’s 70+, she tries hard to maintain an open attitude about certain things. When I approached her a few months ago about what I was going through, she was very forthcoming about her own experiences. And while her experiences were not exactly like mine (let’s face it; no two women’s experiences will ever be exactly the same), being able to talk about it was very liberating, even if I didn’t find “why” behind my own symptomatology.
Janine O’Leary Cobb, a former professor at Vanier College in Montreal, author of Understanding Menopause and founder of ‘A Friend Indeed,” once said that “it seem[s] to be one of the last things women talk about because it’s so entangled with aging and we don’t want to talk about getting older.”
And yet, research suggests that when we do talk about “it” and about getting older, hopefulness and positivity dominates, even as we acknowledge the more negative, i.e. loss and bodily changes, at the same time. And there a majority of women in this study who said that they feel a greater willingness to embrace personal growth and opportunities being presented to them with ease and sense of self as they age, a liberation, if you will.
So, what’s my point? Well, I’m not suggesting that we embrace the sugar-coated version of perimenopause and menopause that many advertisers would lead us to believe. But if we start having conversations with our gal pals and our mothers and colleagues, well, maybe we can begin moving towards removing the stigma that surrounds the “change” and aging once and for all.
Knowledge and exchange are certainly positive, powerful aphrodisiacs for growth.
Wednesday Bubble: Refresh your outlook. With Gynetone…
[Image: http://www.decodog.com/inven/medical.html. All trademark rights reserved]
Gynetone. Sounds like a band, right? But this band won’t be music to your ears.
Gynetone Repetabs, an early form of hormone replacement therapy evidently was formulated to refresh more than your outlook. And the tagline “without the “physiologic borders of either hormone” had a whole lotta subtext.
Interestingly, this nifty hormone replacement pill contained ethinylestradiol (the first orally, active semi-synthetic estrogen used) and methyltestosterone of all things. Methyltestosterone is an anabolic steroid used to treat testosterone deficiency in men. It also stimulates aggression.
Alter your attitude? Sure, we’ll just give you a dose of aggression and your ‘swan song’ outlook will turn you into the Amazing Hulk. Your new song? Momma gonna knock you out?!
Read More
Etymologically speaking…Friday Folly – The Man
Ever wonder who’s responsible?!
I give you….
The Man.
I put a spell on you?
Any regular reader of this blog knows that I love vintage advertising, namely because it’s so medically and politically inappropriate for today’s times.
I stumbled across this doosie in my weekly research:
Barbituates – they’re not for the 60s any longer. In fact, even Wyeth Pharma got ‘down’ on this triple barb combination first produced in 1936 and taken off the market in 1996. That’s sixty years of drug haze-induced. hypnotic sleep, including Marilyn Monroe’s. But I digress.
Ethobral was also used for menopausal women in dire need of a few ‘zzzs – check out the small copy above the graphic:
Sleep for the menopausal patient.
I put a spell on you? Indeed. A spell called Ethobral. I wonder how many women were hooked on these baby barbs in the 1930s, ’40s and ’50s!
Read MoreArchives
Tags
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.